Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Abstract Introduction Neurodegeneration appears to be the biological mechanism most proximate to cognitive decline in Alzheimer's disease. We test whether t‐tau and alternative biomarkers of neurodegeneration—neurogranin and neurofilament light protein (NFL)—add value in predicting subclinical...

Full description

Bibliographic Details
Published in:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Main Authors: Andrew P. Merluzzi, Nicholas M. Vogt, Derek Norton, Erin Jonaitis, Lindsay R. Clark, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin
Format: Article
Language:English
Published: Wiley 2019-01-01
Subjects:
Alzheimer's disease
Biomarkers
Cognition
Neurodegeneration
Amyloid
Cognitive decline
Online Access:https://doi.org/10.1016/j.trci.2019.02.004

Internet

https://doi.org/10.1016/j.trci.2019.02.004

Similar Items